24/7 Market News Snapshot 18 September, 2024 – Exicure, Inc. Common Stock (NASDAQ:XCUR)

September 18, 2024

DENVER, Colo., 18 September, 2024 (247marketnews.com) – (NASDAQ:XCUR) are discussed in this article.
Exicure, Inc. (XCUR) has experienced a remarkable surge in its stock price, which soared by over 212.58%, opening at $2.11 and reaching a high of $6.908 with a significant trading volume of 4.79 million shares. This surge reflects heightened investor interest, potentially bolstered by positive developments within the company and favorable trends in the biotechnology sector.

Adding to this momentum, Exicure has received confirmation from the Nasdaq Hearings Panel regarding the continuation of its stock listing on The Nasdaq Capital Market. The Panel has granted the company an extension until November 14, 2024, to demonstrate compliance with all necessary listing criteria. This development follows Exicure’s commendable efforts to regain adherence to Nasdaq’s minimum bid price requirement, alongside a strategic financial maneuver that involved exchanging approximately $1,000,000 of indebtedness for equity at a conversion price of $3.00 per share.

As a burgeoning leader in biotechnology, Exicure is heavily invested in the development of innovative nucleic acid therapies that specifically target ribonucleic acid pathways. Although the company has recently undertaken a restructuring phase and has paused its clinical and development initiatives, it is actively exploring strategic alternatives aimed at enhancing shareholder value.

Exicure is fully committed to meeting the Nasdaq Panel’s requirements while positioning itself for future growth. The company acknowledges the existing risks and uncertainties that could influence its ability to comply with the stated deadlines. Nevertheless, Exicure remains steadfast in its mission to advance biological solutions, with a focus on improving patient outcomes and providing transparency to its stakeholders throughout this process. As developments unfold, Exicure anticipates continued opportunities for innovation in the marketplace.

Related news for (XCUR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.